ICON plc(ICLR)

Search documents
Icon PLC (ICLR) Upgraded to Buy: Here's What You Should Know
ZACKS· 2024-06-05 17:01
A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as ...
Why Icon PLC (ICLR) is a Top Momentum Stock for the Long-Term
ZACKS· 2024-06-04 14:56
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alo ...
Icon PLC (ICLR) Soars 4.3%: Is Further Upside Left in the Stock?
ZACKS· 2024-05-31 09:11
Icon PLC is a member of the Zacks Medical Services industry. One other stock in the same industry, Elevance Health (ELV) , finished the last trading session 0.4% higher at $507.34. ELV has returned -3.7% over the past month. Icon PLC (ICLR) shares soared 4.3% in the last trading session to close at $322.92. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.6% gain over the past four weeks. For Elevance Health, the consensus EPS e ...
Here's Why Investors Should Retain ICON (ICLR) Stock Now
zacks.com· 2024-05-28 13:46
ICON plc (ICLR) is well-poised to grow in the coming quarters, driven by its meaningful strategic additions to boost growth. The company is committed to advancing innovative solutions to improve developmental outcomes for its customers. Strong, stable solvency buoys optimism. Meanwhile, concerns remain over the adverse macroeconomic impacts as well as currency fluctuations, which may hamper ICON's performance. In the past year, this Zacks Rank #3 (Hold) stock has rallied 57.5% compared with the industry's 6 ...
Icon PLC (ICLR) Up 6.6% Since Last Earnings Report: Can It Continue?
zacks.com· 2024-05-24 16:38
A month has gone by since the last earnings report for Icon PLC (ICLR) . Shares have added about 6.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Icon PLC due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. ICON Q1 Earnings Surpass Estimates, Margins Expand ICON de ...
ICON plc(ICLR) - 2024 Q1 - Earnings Call Transcript
2024-04-25 19:52
ICON Public Limited Company (NASDAQ:ICLR) Q1 2024 Earnings Call Transcript April 25, 2024 8:00 AM ET Company Participants Kate Haven - VP of IR Steve Cutler - CEO Brendan Brennan - CFO Conference Call Participants Adam Chazan - TD Cowen Max Smock - William Blair Casey Woodring - JPMorgan Ann Hynes - Mizuho Securities Dan Leonard - UBS Michael Ryskin - Bank of America Eric Coldwell - Baird Patrick Donnelly - Citi Justin Bowers - Deutsche Bank David Windley - Jefferies Elizabeth Anderson - Evercore ISI Jack M ...
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
Zacks Investment Research· 2024-04-25 18:46
ICON plc (ICLR) delivered first-quarter 2024 adjusted earnings per share of $3.47, an increase of 19.7% from the year-ago period’s figure. The metric surpassed the Zacks Consensus Estimate by 0.9%.RevenuesTotal revenues in the first quarter rose 5.7% year over year to $2.09 billion. The metric surpassed the Zacks Consensus Estimate by 0.08%.Gross business wins in the first quarter were $3.11 billion and cancellations were $460 million. This resulted in net business wins of $2.65 billion and a book-to-bill o ...
ICON plc(ICLR) - 2024 Q1 - Earnings Call Presentation
2024-04-25 15:53
0600 ICON Q1 2024 Results Period Ended March 31, 2024 April 24, 2024 Forward Looking Statement Statements included in this presentation which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Forward-looking statements include statements regarding our financial guidance and outlook, and may be identified by the use of future tense or other forward ...
Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research· 2024-04-24 22:56
Icon PLC (ICLR) came out with quarterly earnings of $3.47 per share, beating the Zacks Consensus Estimate of $3.44 per share. This compares to earnings of $2.90 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.87%. A quarter ago, it was expected that this contract research organization would post earnings of $3.44 per share when it actually produced earnings of $3.46, delivering a surprise of 0.58%.Over the last four quarters ...
ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
Zacks Investment Research· 2024-04-18 15:41
ICON plc’s (ICLR) focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added positive. The stock carries a Zacks Rank #2 (Buy) currently.ICON is gaining from its focused patient, site and data strategy, which is helping it to improve site identification and study placement, patient recruitment and retention. In this regard, Accellacare, ICON's global clinical research network, is successfully offering customers a wide range of sta ...